Entera Bio Stock Profit Margin
| ENTX Stock | USD 2.52 0.12 5.00% |
Entera Bio fundamentals help investors to digest information that contributes to Entera Bio's financial success or failures. It also enables traders to predict the movement of Entera Stock. The fundamental analysis module provides a way to measure Entera Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Entera Bio stock.
| Last Reported | Projected for Next Year | ||
| Net Loss | (112.18) | (106.57) |
Entera | Profit Margin |
Entera Bio Company Profit Margin Analysis
Entera Bio's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Entera Bio Profit Margin | -106.57 |
Most of Entera Bio's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Entera Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Entera Profit Margin Driver Correlations
Understanding the fundamental principles of building solid financial models for Entera Bio is extremely important. It helps to project a fair market value of Entera Stock properly, considering its historical fundamentals such as Profit Margin. Since Entera Bio's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Entera Bio's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Entera Bio's interrelated accounts and indicators.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Entera Pretax Profit Margin
Pretax Profit Margin |
|
Entera Bio Current Valuation Drivers
We derive many important indicators used in calculating different scores of Entera Bio from analyzing Entera Bio's financial statements. These drivers represent accounts that assess Entera Bio's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Entera Bio's important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 19.9M | 73.7M | 21.0M | 17.4M | 20.0M | 19.0M | |
| Enterprise Value | 11.7M | 49.1M | 8.8M | 6.8M | 7.8M | 7.4M |
Entera Bio ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Entera Bio's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Entera Bio's managers, analysts, and investors.Environmental | Governance | Social |
Entera Fundamentals
| Return On Equity | -1.45 | ||||
| Return On Asset | -0.71 | ||||
| Operating Margin | (71.93) % | ||||
| Current Valuation | 81.79 M | ||||
| Shares Outstanding | 36.83 M | ||||
| Shares Owned By Insiders | 19.12 % | ||||
| Shares Owned By Institutions | 26.63 % | ||||
| Number Of Shares Shorted | 95.79 K | ||||
| Price To Earning | 2.10 X | ||||
| Price To Book | 13.70 X | ||||
| Price To Sales | 937.55 X | ||||
| Revenue | 14 K | ||||
| Gross Profit | 9 K | ||||
| EBITDA | (8.8 M) | ||||
| Net Income | (8.89 M) | ||||
| Cash And Equivalents | 17.28 M | ||||
| Cash Per Share | 0.60 X | ||||
| Total Debt | 390 K | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 10.89 X | ||||
| Book Value Per Share | 0.18 X | ||||
| Cash Flow From Operations | (7.31 M) | ||||
| Short Ratio | 0.45 X | ||||
| Earnings Per Share | (0.26) X | ||||
| Target Price | 10.0 | ||||
| Number Of Employees | 17 | ||||
| Beta | 1.59 | ||||
| Market Capitalization | 92.82 M | ||||
| Total Asset | 11.77 M | ||||
| Retained Earnings | (104.39 M) | ||||
| Working Capital | 10.17 M | ||||
| Current Asset | 8.46 M | ||||
| Current Liabilities | 7.64 M | ||||
| Net Asset | 11.77 M |
About Entera Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Entera Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Entera Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Entera Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Entera Stock Analysis
When running Entera Bio's price analysis, check to measure Entera Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entera Bio is operating at the current time. Most of Entera Bio's value examination focuses on studying past and present price action to predict the probability of Entera Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entera Bio's price. Additionally, you may evaluate how the addition of Entera Bio to your portfolios can decrease your overall portfolio volatility.